Statement from FDA Commissioner Scott Gottlieb, M.D. on the agency ’s 2019 policy and regulatory agenda for continued action to forcefully address the tragic epidemic of opioid abuse
FDA outlines 2019 policy and regulatory agenda for continued action to forcefully address the tragic epidemic of opioid abuse.
Source: Food and Drug Administration - Category: American Health Source Type: news
More News: American Health | Epidemics | Epidemiology | Food and Drug Administration (FDA) | Substance Abuse